Arbutus Biopharma (ABUS) earnings, Aug 12, 2026: EPS −400%, stock −1.7%
In brief
Arbutus Biopharma reported on Aug 12, 2026. Earnings per share changed −400% year over year, 50.0% below the estimate; revenue −91%. The stock opened with a −1.7% gap and closed the day −1.7% (Aug 12, 2026). The stock is now 32.7% below its 52-week high, −20.4% over 12 months. Next report: Nov 11, 2026.
EPS vs estimate−50.0%
EPS, YoY−400%
Revenue, YoY−91%
Gap · day−1.7% · −1.7%
EPS growth by quarter, YoY
Price reaction to earnings
| Report | Gap | Day |
|---|---|---|
| May 13, 2026 | +4.2% | 0.0% |
| Aug 12, 2026 | −1.7% | −1.7% |
Next-quarter estimates, ratings and the ABUS chart are in the terminal.
Open the terminalFAQ
When is Arbutus Biopharma's next earnings report?
Nov 11, 2026. The date comes from daily data and is corrected if the company moves it.
How did Arbutus Biopharma stock react to the report?
Opening gap −1.7%, day's result −1.7%.
Did Arbutus Biopharma's earnings grow?
Earnings per share fell 400% year over year.
What is an earnings gap?
The jump between the close before and the open after the report. A big gap up often means large buyers are revaluing the company.